Jian Shen

Dr. Jian Shen

Medical College of Wisconsin
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YCYao Chen
Yao Chen
RZRyan A. Zander
Ryan A. Zander
XWXiaopeng Wu
Xiaopeng Wu
DSDavid M. Schauder
David M. Schauder
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
WCWeiguo Cui
Weiguo Cui

24 February 2022 in Immunity
Verified
Journal Article
Closed access
RZRyan Zander
Ryan Zander
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
YCYao Chen
Yao Chen
PTPaytsar Topchyan
Paytsar Topchyan
JSJian Shen
Jian Shen
WCWeiguo Cui
Weiguo Cui

14 February 2025 in Science
Verified
Journal Article
Closed access
EFEric Fagerberg
Eric Fagerberg
JAJohn Attanasio
John Attanasio
CDChristine Dien
Christine Dien
JSJaiveer Singh
Jaiveer Singh
EKEmily A. Kessler
Emily A. Kessler
NJNikhil S. Joshi
Nikhil S. Joshi
Naïve CD8 T cells have the potential to differentiate into a spectrum of functional states during an immune response. How these developmental decisions are made and what mechanisms exist to suppress differentiation toward alternative fates remains unclear. We employed in vivo CRISPR-Cas9–based perturbation sequencing to assess the role of ~40 transcription factors (TFs) and epigenetic modulators in T cell fate decisions. Unexpectedly, we found that knockout of the TF Klf2 resulted in aberrant differentiation to exhausted-like CD8 T cells during acute infection. KLF2 was required to suppress the exhaustion-promoting TF TOX and to enable the TF TBET to drive effector differentiation. KLF2 was also necessary to maintain a polyfunctional tumor-specific progenitor state. Thus, KLF2 provides effector CD8 T cell lineage fidelity and suppresses the exhaustion program.

17 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AKAchia Khatun
Achia Khatun
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
RZRyan Zander
Ryan Zander
DSDavid M. Schauder
David M. Schauder
JSJeremy P. Snook
Jeremy P. Snook
WCWeiguo Cui
Weiguo Cui
Tracking how individual naive T cells from a natural TCR repertoire clonally expand, differentiate, and make lineage choices in response to an infection has not previously been possible. Here, using single-cell sequencing technology to identify clones by their unique TCR sequences, we were able to trace the clonal expansion, differentiation trajectory, and lineage commitment of individual virus-specific CD4 T cells during an acute lymphocytic choriomeningitis virus (LCMV) infection. Notably, we found previously unappreciated clonal diversity and cellular heterogeneity among virus-specific helper T cells. Interestingly, although most naive CD4 T cells gave rise to multiple lineages at the clonal level, ∼28% of naive cells exhibited a preferred lineage choice toward either Th1 or TFH cells. Mechanistically, we found that TCR structure, in particular the CDR3 motif of the TCR α chain, skewed lineage decisions toward the TFH cell fate.

20 August 2021 in Cells
Verified
Journal Article
Open access
PDF file
YCYao Chen
Yao Chen
JSJian Shen
Jian Shen
MKMoujtaba Kasmani
Moujtaba Kasmani
PTPaytsar Topchyan
Paytsar Topchyan
WCWeiguo Cui
Weiguo Cui
During acute infections, CD8+ T cells form various memory subpopulations to provide long-lasting protection against reinfection. T central memory (TCM), T effector memory (TEM), and long-lived effector (LLE) cells are circulating memory populations with distinct plasticity, migration patterns, and effector functions. Tissue-resident memory (TRM) cells permanently reside in the frontline sites of pathogen entry and provide tissue-specific protection upon reinfection. Here, using single-cell RNA-sequencing (scRNA-seq) and bulk RNA-seq, we examined the different and shared transcriptomes and regulators of TRM cells with other circulating memory populations. Furthermore, we identified heterogeneity within the TRM pool from small intestine and novel transcriptional regulators that may control the phenotypic and functional heterogeneity of TRM cells during acute infection. Our findings provide a resource for future studies to identify novel pathways for enhancing vaccination and immunotherapeutic approaches.

31 January 2025 in Science Immunology
Verified
Journal Article
Closed access
CGCatarina Gago da Graça
Catarina Gago da Graça
ASAmania A. Sheikh
Amania A. Sheikh
DNDane M. Newman
Dane M. Newman
LWLifen Wen
Lifen Wen
SLSining Li
Sining Li
DUDaniel T. Utzschneider
Daniel T. Utzschneider
Stem-like T cells are attractive immunotherapeutic targets in patients with cancer given their ability to proliferate and differentiate into effector progeny. Thus, identifying T cells with enhanced stemness and understanding their developmental requirements are of broad clinical and therapeutic interest. Here, we demonstrate that during acute infection, the transcriptional regulator inhibitor of DNA binding 3 (ID3) identifies stem-like T cells that are uniquely adapted to generate precursors of exhausted T (Tpex) cells in response to chronic infection or cancer. Expression of ID3 itself enables Tpex cells to sustain T cell responses in chronic infection or cancer, whereas loss of ID3 results in impaired maintenance of CD8 T cell immunity. Furthermore, we demonstrate that interleukin-1 (IL-1) family members, including IL-36β and IL-18, promote the generation of ID3 + T cells that mediate superior tumor control. Overall, we identify ID3 as a common denominator of stem-like T cells in both acute and chronic infections that is specifically required to sustain T cell responses to chronic stimulation.